LTB4R
Leukotriene B4 receptor 1
Also known as: BLTR, CMKRL1, GPR16, LT4R1_HUMAN, LTB4R1, P2RY7, P2Y7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15722
- Gene
- LTB4R
- Ensembl
- ENSG00000213903
- Chromosome
- 14
- Canonical length
- 352 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable G protein-coupled peptide receptor activity and leukotriene B4 receptor activity. Predicted to be involved in neuropeptide signaling pathway. Predicted to act upstream of or within signal transduction. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
352 residues, UniProt reviewed canonical sequence.
>Q15722|LTB4R
1 MNTTSSAAPP SLGVEFISLL AIILLSVALA VGLPGNSFVV WSILKRMQKR SVTALMVLNL
61 ALADLAVLLT APFFLHFLAQ GTWSFGLAGC RLCHYVCGVS MYASVLLITA MSLDRSLAVA
121 RPFVSQKLRT KAMARRVLAG IWVLSFLLAT PVLAYRTVVP WKTNMSLCFP RYPSEGHRAF
181 HLIFEAVTGF LLPFLAVVAS YSDIGRRLQA RRFRRSRRTG RLVVLIILTF AAFWLPYHVV
241 NLAEAGRALA GQAAGLGLVG KRLSLARNVL IALAFLSSSV NPVLYACAGG GLLRSAGVGF
301 VAKLLEGTGS EASSTRRGGS LGQTARSGPA ALEPGPSESL TASSPLKLNE LNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LTB4R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- skin: 106 nTPM
- esophagus: 99 nTPM
- vagina: 50 nTPM
- cervix: 46 nTPM
- spleen: 40 nTPM
- salivary gland: 23 nTPM
Single-cell type
- proximal tubule cells: 8.3 nCPM
- papillary tip epithelial cells: 6.7 nCPM
- ependymal cells: 6 nCPM
- microglia: 5.2 nCPM
- renal collecting duct intercalated cells: 4.9 nCPM
- distal convoluted tubule cells: 3.9 nCPM
Immune cell
- neutrophil: 101 nTPM
- eosinophil: 41 nTPM
- classical monocyte: 39 nTPM
- basophil: 17 nTPM
- total PBMC: 14 nTPM
- myeloid DC: 11 nTPM
Brain region
- thalamus: 2.9 nTPM
- medulla oblongata: 2.3 nTPM
- pons: 2.3 nTPM
- white matter: 2.3 nTPM
- cerebellum: 2.2 nTPM
- choroid plexus: 2.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0.12
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- -0.34
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- immune response
- inflammatory response
- muscle contraction
- neuropeptide signaling pathway
- phospholipase C-activating G protein-coupled receptor signaling pathway
Molecular functions
- G protein-coupled peptide receptor activity
- leukotriene B4 receptor activity
- leukotriene receptor activity
- nucleotide binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LTB4R as an antibody target. Whether an autoantibody or antibody against LTB4R could matter depends on whether native LTB4R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LTB4R is annotated at the cell surface, where native LTB4R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LTB4R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...